Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
ADMA ADMA Biologics
- 17.400
- -0.500-2.79%
Close Dec 20 16:00 ET
- 17.400
- 0.0000.00%
Post 20:01 ET
4.11BMarket Cap64.44P/E (TTM)
17.960High17.080Low6.94MVolume17.160Open17.900Pre Close121.09MTurnover2.99%Turnover RatioLossP/E (Static)236.39MShares23.64052wk High17.74P/B4.04BFloat Cap4.27052wk Low--Dividend TTM232.07MShs Float23.640Historical High--Div YieldTTM4.92%Amplitude1.010Historical Low17.444Avg Price1Lot Size
ADMA Biologics Key Stats
EPS
According to the latest financial report of ADMA Biologics, the latest earnings per share (TTM) for the company is 0.15. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about ADMA Biologics's free cash flow? The latest report shows it as 23.93M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ADMA Biologics shows that the company's current ratio is 7.09, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ADMA Biologics, the quick ratio is 3.05, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of ADMA Biologics? The latest ROE figure is 17.09%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ADMA Biologics, the total asset return on investment (ROA) is 9.36%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ADMA Biologics's latest financial report to see how their gross margin is doing - currently at 49.78%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ADMA Biologics, the net profit margin is 29.96%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...